Business Wire

HKSTP Calls Innovators Worldwide to Join the Virtual Elevator Pitch Competition 2020

Share

Hong Kong Science and Technology Parks Corporation (HKSTP) announced that the Elevator Pitch Competition 2020 (EPiC 2020) is now inviting applications from around the world. Given current global circumstances, HKSTP will stage the event on a virtual platform for the first time. Local and international startups and innovators can go beyond the geographic boundaries and unlock tremendous opportunities at EPiC 2020, which will take place from 6 to 13 November.

Marking its fifth anniversary, EPiC 2020 comprises a series of one-week events for the 150 contestants shortlisted from a competitive pool of global-wide applications. The startups will simulate the signature 60-second elevator ride to pitch their innovative business ideas virtually via a 1-minute video to a judging panel of major investors and industry leaders, who will select the top 10 finalists. The finalists will be announced during the final pitching competition on 6 November where they will battle to be named EPiC champion of 2020 in a 5-minute presentation plus a Q&A session.

Following the Pitching Competition, the contestants also have the chance to explore cross-border business and investment opportunities to help propel their technology innovation across all key stages of the entrepreneurial journey. The Global Matching Day programme, which will happen from 9 to 12 November, connects the best startups with thousands of leading investors and corporate leaders to explore business opportunities in the Greater Bay Area and Asia Pacific. The “Investment x Corporate Innovation Conference” on 13 November concludes the EPiC week by bringing together I&T heavyweights and global pioneers to discuss the regional investment opportunities and share the ways to drive corporate innovation and growth.

Albert Wong, CEO of HKSTP, said, “EPiC 2020, as our annual flagship event, is a unique platform to connect international innovation and technology (I&T) talent, startups and investors to accelerate global partnerships and collaborations. We are hosting our first-ever virtual EPiC this year to drive greater value and synergies among entrepreneurs and corporates across the globe in view of market challenges.”

“At HKSTP, our belief in entrepreneurial spirit and our commitment to sustaining the growth of the I&T ecosystem remain as strong as ever. We strive to provide a beacon of growth opportunity for startups around the world and support them across the critical early stages of their innovation journey.”

Last year, the competition attracted a record number of 650 entries from 48 countries and cities across the globe. Over 70% of the finalists were from 33 different overseas markets, including Australia, Canada, India, Japan, New Zealand, Singapore and the United States, among others. The event brought more than 1,000 entrepreneurs, venture capital firms, angel investors, industry players, incubators, accelerators and tech disruptors together, to sustain the I&T ecosystem in Hong Kong.

Who can apply:

  • Tech startups that are less than five years old and have received less than US$10 million in funding by 31 March 2020 OR individuals who have not yet established any companies
  • Ideas should focus on one of the four technology areas: Artificial Intelligence & Robotics, FinTech, Health Technology and Smart City.

Applications will close on 19 October 2020, at 23:59 hrs, Hong Kong time.

Please visit https://epic.hkstp.org/ for more detailed information on EPiC 2020.

List of awards and prizes

Award

Cash Prize
(for each winner)

Champion

US$100,000

4 Tech Winners
(Artificial Intelligence & Robotics, FinTech, Health Technology and Smart City)

US$10,000

Top 10 Finalists

US$6,000

# # #

About Hong Kong Science and Technology Parks Corporation

Comprising Science Park, InnoCentre and Industrial Estates, Hong Kong Science & Technology Parks Corporation (HKSTP) is a statutory body dedicated to building a vibrant innovation and technology ecosystem to connect stakeholders, nurture technology talents, facilitate collaboration, and catalyse innovations to deliver social and economic benefits to Hong Kong and the region.

Established in May 2001, HKSTP has been driving the development of Hong Kong into a regional hub for innovation and growth in several focused clusters including Electronics, Information & Communications Technology, Green Technology, Biomedical Technology, Materials and Precision Engineering. We enable science and technology companies to nurture ideas, innovate and grow, supported by our R&D facilities, infrastructure, and market-led laboratories and technical centres with professional support services. We also offer value added services and comprehensive incubation programmes for technology start-ups to accelerate their growth.

Technology businesses benefit from our specialised services and infrastructure at Science Park for applied research and product development; enterprises can find creative design support at InnoCentre; while skill-intensive businesses are served by our three industrial estates at Tai Po, Tseung Kwan O and Yuen Long. More information about HKSTP is available at www.hkstp.org.

Contact information

Hong Kong Science and Technology Parks Corporation
Sarah Poon
Tel: +852 2629 7015
Email: sarah.poon@hkstp.org

Edelman Public Relations
Janice Wong
Tel: +852 2837 4775
Email: Janice.Wong@edelman.com / Edelmanhkstppr@edelman.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Emory University to Host a Live Webcast With His Holiness the Dalai Lama30.11.2020 16:39:00 CETPress release

The Center for Contemplative Science and Compassion-Based Ethics at Emory University will host a live webinar with His Holiness the Dalai Lama on Tuesday, December 8, 2020. A discussion titled “The Necessity of Compassion for the Survival of Humanity” will feature the Dalai Lama in conversation with Melani A. Walton, co-founder of the Rob and Melani Walton Foundation, and Dr. Sanjay Gupta, chief medical correspondent for CNN. (For speaker photos click here.) The webcast begins at 10:30pm ET on Dec. 8, 2020 (Dec. 9 @ 9:00am India Standard Time) and will be simulcast in 14 languages. It is FREE of charge and open to anyone who’d like to participate. Advance registration is encouraged at https://compassionshift.emory.edu. “With so many urgent concerns impacting our world, the time is right to start a global conversation about the importance of compassion,” said Lobsang Tenzin Negi, executive director of Emory University’s Center for Contemplative Science and Compassion-Based Ethics. “For

Flexjet Advances European Expansion with Delivery of First Embraer Praetor 60030.11.2020 15:03:00 CETPress release

Flexjet Ltd., offering travelers access to the world’s most luxurious fleet of private jets, accepted delivery of the first Praetor 600 aircraft in its European-based fleet, marking a significant milestone in the expansion of the company’s global business. Flexjet is the only shared-ownership/fractional provider of the Praetor 600, part of a US$1.4 billion order for Embraer Executive Jets, a division of Embraer S.A. (NYSE: ERJ; BM&FBOVESPA: EMBR3), that was announced in October 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005564/en/ Flexjet Embraer Praetor 600 super midsized aircraft part of the European-based Flexjet fleet. (Photo: Business Wire) European Managing Director Marine Eugène leads the team headquartered at Flexjet House in the Mayfair neighbourhood in the west end of London. In addition, Flexjet has opened facilities including a European Tactical Control Centre in the United Kingdom to coordinate f

Kymeta™ Announces Commercial Availability of its Next-Generation Antenna, Terminal, and Services Making Mobile Global30.11.2020 15:00:00 CETPress release

Kymeta (www.kymetacorp.com)—the communications company making mobile global—announced that the Kymeta™ u8 and Kymeta Connect™ are available for government and commercial purchase after November 30, 2020, unlocking the potential of broadband satellite connectivity and cellular networks to satisfy the overwhelming demand for communications on the move. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005022/en/ Kymeta’s next-generation solutions are built for mobility and designed to meet the needs of global defense agencies, government, first responders, and commercial customers. Kymeta’s products and services have been field deployed for three years and the demand for the Kymeta u8 presales has already exceeded expectations. With the introduction of the Kymeta u8, the company has meaningfully increased antenna throughput and significantly reduced the total cost of ownership. Kymeta’s new products and services offer a bre

Diamond Standard Commodity and Token to List on INX30.11.2020 15:00:00 CETPress release

INX Limited, the blockchain-based platform for trading digital securities and cryptocurrencies, announces today that it has signed a letter of intent with Diamond Standard to list the world’s first diamond commodity—the Diamond Standard Coin. The Coin is a digital and physical asset: a standardized set of diamonds with a wireless chip enabling it to trade as a token on the INX trading platform. The availability of the Coin on the INX platform is pending regulatory approval for the $25 million initial public commodity offering. This diamond commodity makes a $1.2 trillion hard asset available to institutional investors for the first time. Diamond Standard recently announced its plan to launch an ETF on the NYSE under the ticker DIAM, and an agreement to list futures on the CME Globex via the MGEX. INX is providing an electronic spot market for the Diamond Standard Coin. Investors who acquire a Diamond Standard Token on the INX platform are transacting the physical commodity itself, and

Inversago Pharma Continues to Rapidly Expand Its Leadership Team and Appoints Glenn D. Crater, MD, FCCP as Chief Medical Officer30.11.2020 14:00:00 CETPress release

Inversago Pharma Inc. (“the Company” or “Inversago”), the peripheral CB1 blockade company, today announced it has appointed Glenn D. Crater, MD, FCCP as its Chief Medical Officer. In this position, Dr. Crater will oversee the clinical development of Inversago’s lead compound for Prader-Willi syndrome, INV-101, as well as its pipeline of other peripherally-acting CB1 inverse agonists in several other indications. “The appointment of a Chief Medical Officer is an essential element of our corporate strategy as we have entered the clinical phase with our lead compound”, said François Ravenelle, PhD, CEO and founder of Inversago Pharma. “Glenn brings a broad range of relevant experiences in all aspects of drug development and regulatory interactions and I trust he will have a strong impact on the science we develop at Inversago, helping us meet our objective: developing safe and potent inverse agonists of peripheral CB1 receptors”, added Dr. Ravenelle. “I am very excited to join Inversago a

Kinaset Therapeutics Launches with a $40M Series A Financing to Develop Novel Therapeutics for Respiratory Diseases and an Exclusive Global License Agreement with Vectura Group for KN-002 (VR588), a Novel Anti-Inflammatory30.11.2020 13:00:00 CETPress release

Kinaset Therapeutics, Inc. (“Kinaset” or the “Company”), a newly-founded biopharmaceutical company, today announced a $40 million Series A financing with a blue-chip investor syndicate of 5AM Ventures, Atlas Venture, and Gimv. The Company also announced an exclusive global in-license and services agreement with Vectura Group plc (LSE: VEC) (“Vectura”) to develop and commercialize KN-002 (formerly known as VR588), a novel, inhaled small-molecule pan-JAK inhibitor, for the treatment of eosinophilic and non-eosinophilic severe asthma. A Phase 1/1b clinical trial in healthy volunteers and patients is poised to begin in the first half of 2021. Kinaset is led by an experienced management team and Board of Directors with strong backgrounds in the development of respiratory therapeutics. The company is led by Chief Executive Officer Robert Clarke (formerly Pulmatrix, AIR/Alkermes), Chief Business Officer Roger Heerman (GlaxoSmithKline, Vectura), and Chief Development Officer Frazer Morgan (Vec